Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ) | WebDisclosure

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Headlines Articles Press releases Eckert & Ziegler Strahlen- Und Medizintechnik AG

Home
Companies
Eckert & Ziegler Strahlen- Und Medizintechnik AG

BRIEF

published on 12/03/2025 at 09:05, 1 day 22 hours ago

Eckert & Ziegler et SK Biopharmaceuticals concluent un partenariat sur l'actinium-225

Oncologie Produits Radiopharmaceutiques Actinium-225 SK Biopharmaceutiques Eckert Et Ziegler
BRIEF

published on 12/03/2025 at 09:05, 1 day 22 hours ago

Eckert & Ziegler and SK Biopharmaceuticals Form Actinium-225 Partnership

Oncology Eckert & Ziegler Radiopharmaceuticals Actinium-225 SK Biopharmaceuticals
PRESS RELEASE

published on 12/03/2025 at 09:00, 1 day 22 hours ago

Eckert & Ziegler and SK Biopharmaceuticals Sign Actinium-225 Supply Agreement
Eckert & Ziegler and SK Biopharmaceuticals sign Actinium-225 supply agreement for cancer therapies. Eckert & Ziegler to supply Ac-225 to accelerate SK Biopharmaceuticals' research and development activities in radiopharmaceutical therapies

Eckert & Ziegler Supply Agreement Actinium-225 Cancer Therapies SK Biopharmaceuticals
BRIEF

published on 11/13/2025 at 07:50, 21 days 23 hours ago

Eckert & Ziegler annonce une croissance de ses bénéfices et de son chiffre d'affaires en 2025

Croissance Des Bénéfices Augmentation Des Ventes Revenu Net Prévisions Pour 2025 Segment Médical
BRIEF

published on 11/13/2025 at 07:50, 21 days 23 hours ago

Eckert & Ziegler Reports Earnings and Sales Growth in 2025

Net Income Sales Increase Earnings Growth Medical Segment 2025 Forecast
PRESS RELEASE

published on 11/13/2025 at 07:45, 21 days 23 hours ago

Eckert & Ziegler Achieves Further Earnings Growth and Double-Digit Sales Growth in the Medical Segment
Eckert & Ziegler SE reports double-digit sales growth in the medical segment, with net income rising in the 3rd quarter of 2025. Strong performance outlook for 2025

Financial Results Sales Growth Eckert & Ziegler SE Medical Segment 2025 Forecast
BRIEF

published on 09/19/2025 at 12:05, 2 months 15 days ago

Eckert & Ziegler Receives Approval for GalliaPharm® in Japan

Regulatory Approval Nuclear Medicine Japan Market GalliaPharm® Isotope Technology
BRIEF

published on 09/19/2025 at 12:05, 2 months 15 days ago

Eckert & Ziegler obtient l'autorisation de commercialisation de GalliaPharm® au Japon

Marché Japonais Approbation Réglementaire Médecine Nucléaire GalliaPharm® Technologie Des Isotopes
PRESS RELEASE

published on 09/19/2025 at 12:00, 2 months 15 days ago

Eckert & Ziegler Gains Approval for GalliaPharm® in Japan
Eckert & Ziegler obtains marketing approval in Japan for GalliaPharm® 68Ge/68Ga Radionuclide Generator, expanding access to Gallium-68 diagnostics and supporting precision imaging in healthcare

Eckert & Ziegler Regulatory Approval Japan Nuclear Medicine GalliaPharm
BRIEF

published on 09/09/2025 at 11:35, 2 months 25 days ago

Berenberg Initiates 'Buy' Rating for Eckert & Ziegler with Significant Upside

Buy Recommendation Eckert & Ziegler Price Target Nuclear Medicine Berenberg

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 52 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 57 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 27 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 22 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 27 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 26 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 56 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 36 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 1 minute ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 12 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:14, 13 hours 12 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 27 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 27 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 42 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 42 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE